IOL Chemicals & Pharmaceuticals : Q2FY27 results Highlights

DHARMESH BHATT (Research Analyst) SEBI Registration No. INH000009685 !IOLCP Pharmaceuticals company IOL Chemicals and Pharmaceuticals announced Q2FY27 results : ----Standalone Financial Highlights: ---- Revenue from Operations: For Q2FY27, the standalone revenue from operations stood at Rs 795.03 crore, up 5.13% QoQ from Rs 756.26 crore in Q1FY27, and up 40.09% YoY from Rs 567.53 crore in Q2FY26. For H1FY27, standalone revenue from operations reached Rs 1,551.29 crore, a YoY increase of 38.60% from Rs 1,119.22 crore in H1FY26. Total Income : For Q2FY27, standalone total income was Rs 800.54 crore, increasing 4.72% QoQ compared to Rs 764.44 crore in Q1FY27, and increasing 39.37% YoY compared to Rs 574.41 crore in Q2FY26. For H1FY27, standalone total income registered at Rs 1,564.98 crore, a YoY increase of 38.07% from Rs 1,133.47 crore in H1FY26. Profit Before Tax (PBT): For Q2FY27, standalone PBT stood at Rs 87.25 crore, changing by 0.55% QoQ from Rs 86.77 crore in Q1FY27, and increasing 115.33% YoY from Rs 40.52 crore in Q2FY26. For H1FY27, standalone PBT recorded at Rs 174.02 crore, growing by 102.21% YoY against Rs 86.06 crore in H1FY26. Profit After Tax (PAT): For Q2FY27, standalone PAT arrived at Rs 65.03 crore, reflecting a 0.85% QoQ growth relative to Rs 64.48 crore in Q1FY27, and a 116.77% YoY increase compared to Rs 30.00 crore in Q2FY26. For H1FY27, standalone PAT stood at Rs 129.51 crore, expanding by 102.49% YoY over Rs 63.96 crore in H1FY26. Disclosure /Disclaimer Link: *****